Úsek pro vědu a výzkum

Professional Publications

Author
Title
Year of publication

Publications (3663)

[761]

Formánková, R.; Honzátková, L.; Sieglová, Z.; Starý, J.; Sedláček, P.; Brdička, R.

Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia

[year of publication 2006, impact factor 2.396]

[762]

Kozák, T.; Havrdová, E.; Piťha, J.; Gregora, E.; Pytlík, R.; Maaloufová, J.; Marečková, H.; Kobylka, P.; Vodvářková, Š.

High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis

[year of publication 2006, impact factor 2.396]

[763]

Polák, J.; Koza, V.; Cetkovský, P.; Haškovec, C.

An accelerated-phase CML patient with e19a2 junction of BCR/ABL gene : the first case of transplanted CML with micro BCR

[year of publication 2006, impact factor 2.396]

[764]

Neuwirtova, R.; Fuchs, O.; Holicka, M.; Vostry, M.; Kostecka, A.; Hajkova, H.; Jonasova, A.; Cermak, J.; Cmejla, R.; Pospisilova, D.; Belickova, M.; Siskova, M.; Hochova, I.; Vondrakova, J.; Sponerova, D.; Kadlckova, E.; Novakova, L.; Brezinova, J.; Michalova, K.

Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q- syndrome and in Diamond-Blackfan anemia

[year of publication 2012, impact factor 2.396 ]

[765]

Vonka, V.

Comments on therapeutic cancer vaccines

[year of publication 2012, impact factor 2.393 ]

[766]

Majek, P.; Pecankova, K.; Cermak, J.; Gasova, Z.; Prochazka, B.; Dyr, J.E.

Alpha-2-HS-glycoprotein plasma level decrease correlates with age in patients with myelodysplastic syndromes

[year of publication 2018, impact factor 2.392 ]

[767]

Ryšavá, J.; Dyr, J.E.; Homola, J.; Dostálek, J.; Křížová, P.; Mášová, L.; Suttnar, J.; Briestenský, J.; Santar, I.; Myška, K.; Pecka, M.

Surface interactions of oxidized cellulose with fibrin(ogen) and blood platelets

[year of publication 2006, impact factor 2.391]

[768]

Pekova, S.; Cmejla, R.; Smolej, L.; Kozak, T.; Spacek, M.; Prucha, M.

Identification of a novel, transactivation-defective splicing variant of p53 gene in patients with chronic lymphocytic leukemia

[year of publication 2008, impact factor 2.390]

[769]

Machova Polakova, K.; Lopotova, T.; Klamova, H.; Moravcova, J.

High-resolution melt curve analysis : initial screening for mutations in BCR-ABL kinase domain

[year of publication 2008, impact factor 2.390]

[770]

Veselovska, J.; Pospisilova, D.; Pekova, S.; Horvathova, M.; Solna, R.; Cmejlova, J.; Cmejla, R.; Belickova, M.; Mihal, V.; Stary, J.; Divoky, V.

Most pediatric patients with essential thrombocythemia show hypersensitivity to erythropoietin in vitro, with rare JAK2 V617F-positive erythroid colonies

[year of publication 2008, impact factor 2.390]

[771]

Žáčková, M.; Moučková, D.; Lopotová, T.; Ondráčková, Z.; Klamová, H.; Moravcová, J.

Hsp90: a potential prognostic marker in CML

[year of publication 2012, impact factor 2.390 ]

[772]

Lopotová, T.; Polák, J.; Schwarz, J.; Klamová, H.; Moravcová, J.

Corrigendum to "Expression of four major WT1 splicing variants in acute and chronic myeloid leukemia patients analyzed by newly developed four real-time RT PCRs" [Blood Cells Mol. Dis. 49 (1) (2012) 41-47] (DOI:10.1016/j.bcmd.2012.04.001)

[year of publication 2013, impact factor 2.390 ]

[773]

Vaculik, P.; Plchova, H.; Moravec, T.; Hoffmeisterova, H.; Cerovska, N.; Smahel, M.

Potato virus X displaying the E7 peptide derived from human papillomavirus type 16: a novel position for epitope presentation

[year of publication 2014, impact factor 2.390 ]

[774]

Jamison, J.M.; Gilloteaux, J.; Perlaky, L.; Thiry, M.; Smetana, K.; Neal, D.; McGuire, K.; Summers, J.L.

Nucleolar changes and fibrillarin redistribution following Apatone treatment of human bladder carcinoma cells

[year of publication 2010, impact factor 2.381]

[775]

Tachezy, R.; Hrbacek, J.; Heracek, J.; Salakova, M.; Smahelova, J.; Ludvikova, V.; Svec, A.; Urban, M.; Hamsikova, E.

HPV persistence and its oncogenic role in prostate tumors

[year of publication 2012, impact factor 2.373 ]

[776]

Moravcová, J.; Rulcová, J.; Polák, J.; Klamová, H.; Haškovec, C.; Zemanová, Z.

CML patient with rare b2a3 (e13a3) variant of BCR-ABL transcript : complete molecular response to imatinib.

[year of publication 2006, impact factor 2.372]

[777]

Zemanova, Z.; Michalova, K.; Sindelarova, L.; Smisek, P.; Brezinova, J.; Ransdorfova, S.; Vavra, V.; Dohnalova, A.; Stary, J.

Prognostic value of structural chromosomal rearrangements and small cell clones with high hyperdiploidy in children with acute lymphoblastic leukemia.

[year of publication 2006, impact factor 2.372]

[778]

Čermák, J.; Beličková, M.; Krejčová, H.; Michalová, K.; Žilovcová, S.; Zemanová, Z.; Březinová, J.; Sieglová, Z.

The presence of clonal cell populations in peripheral blood and bone marrow of patients with refractory cytopenia with multilineage dysplasia but not in patients with refractory anemia may reflect a multistep pathogenesis of myelodysplasia.

[year of publication 2006, impact factor 2.372]

[779]

Cermak, J.; Kacirkova, P.; Mikulenkova, D.; Michalova, K.

Impact of transfusion dependency on survival in patients with early myelodysplastic syndrome without excess of blasts

[year of publication 2009, impact factor 2.358]

[780]

Zuna, J.; Prouzova, Z.; Kalina, T.; Lizcova, L.; Zemanova, Z.; Muzikova, K.; Rahmatova, S.; Meijerink, J.P.P.; Trka, J.

Backtracking of ALL to cord blood

[year of publication 2009, impact factor 2.358]